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Abstract
Introduction: Pre-hospital induction of therapeutic mild hypothermia (TH) may reduce post-cardiac arrest brain
injury in patients resuscitated from out-of-hospital cardiac arrest. Most often, it is induced by a rapid intravenous
administration of as much as 30 ml/kg of cold crystalloids. We decided to assess the pre-hospital cooling effectivity
of this approach by using a target dose of 15-20 ml/kg of 4°C cold normal saline in the setting of the physician-
staffed Emergency Medical Service. The safety and impact on the clinical outcome have also been analyzed.
Methods: We performed a prospective observational study with a retrospective control group. A total of 40
patients were cooled by an intravenous administration of 15-20 ml/kg of 4°C cold normal saline during transport
to the hospital (TH group). The pre-hospital decrease of tympanic temperature (TT) was analyzed as the primary
endpoint. Patients in the control group did not undergo any pre-hospital cooling.
Results: In the TH group, administration of 12.6 ± 6.4 ml/kg of 4°C cold normal saline was followed by a pre-
hospital decrease of TT of 1.4 ± 0.8°C in 42.8 ± 19.6 min (p < 0.001). The most effective cooling was associated
with a transport time duration of 38-60 min and with an infusion of 17 ml/kg of cold saline. In the TH group, a
trend toward a reduced need for catecholamines during transport was detected (35.0 vs. 52.5%, p = 0.115). There
were no differences in demographic variables, comorbidities, parameters of the cardiopulmonary resuscitation and
in other post-resuscitation characteristics. The coupling of pre-hospital cooling with subsequent in-hospital TH
predicted a favorable neurological outcome at hospital discharge (OR 4.1, CI95% 1.1-18.2, p = 0.046).
Conclusions: Pre-hospital induction of TH by the rapid intravenous administration of cold normal saline has been
shown to be efficient even with a lower dose of coolant than reported in previous studies. This dose can be
associated with a favorable impact on circulatory stability early after the return of spontaneous circulation and,
when coupled with in-hospital continuation of cooling, can potentially improve the prognosis of patients.
Trial Registration: ClinicalTrials (NCT): NCT00915421
Introduction
Therapeutic mild hypothermia (TH) has become a rou-
tine part of in-hospital post-resuscitation support. It has
been recommended that the target therapeutic tempera-
ture be reached as soon as possible [1]. Thus, in success-
fully resuscitated out-of-hospital cardiac arrest (OHCA)
patients, pre-hospital initiation of cooling appears to be a
method of choice. A few studies demonstrating the
efficacy and safety of this strategy, predominantly for the
technique of rapid intravenous administration of cold
crystalloids (RIVA), have been published [2-6]. In gen-
eral, a target dose of 30 mL/kg was recommended. How-
ever, this dose is not easy to reach in routine practice,
especially when transport time is short. Therefore, we
performed a clinical study to assess a pre-hospital cooling
effectivity of RIVA with the target dose of 15 to 20 mL/kg
of 4°C cold normal saline in the setting of the physician-
staffed emergency medical service (EMS). The safety and
impact on the clinical outcome have also been analyzed. * Correspondence: skulec@email.cz
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We performed a multicenter prospective observational
study with a retrospective control group in 18 physician-
staffed bases of the EMS and in 23 intensive care units
(ICUs) of two administrative regions of the Czech Repub-
lic (tributary area of 1,840,000 inhabitants). The study
was conducted in accordance with the Declaration of
Helsinki; was approved by the ethics committee of Uni-
versity Hospital Hradec Kralove, by the Czech Society for
Emergency and Disaster Medicine, the Czech Society of
A n a e s t h e s i o l o g ya n dI n t e n s i v eC a r eM e d i c i n e ,a n dt h e
Czech Society of Intensive Care Medicine; and was
endorsed by the Czech Clinical Trial Network of the
Czech Society of Anaesthesiology and Intensive Care
Medicine and the Czech Society of Intensive Care Medi-
cine. The study was named PRE-COOL (Pre-Hospital
Cooling in Cardiac Arrest Patients). Because the study
was non-randomized and no new drug, therapeutic pro-
cedure, or diagnostic procedure was evaluated, written
informed consent was not required.
Patients meeting the inclusion and exclusion criteria
were included in the prospective group with active cool-
ing (TH group). The inclusion criterion was successfully
resuscitated OHCA with any initial rhythm, persistence
of coma, and requirement of mechanical ventilation.
Exclusion criteria were cardiac arrest of traumatic origin,
patient conscious after short cardiopulmonary resuscita-
tion (CPR), coma of origin other than cardiac arrest,
acute pulmonary edema, active severe bleeding [7], circu-
latory shock defined as hypotension irresponsive to
volume expansion or vasopressoric support or both,
severe bradycardia requiring transcutaneous cardiac
pacing, severe sepsis/septic shock [8], pregnancy, and a
do-not-resuscitate or do-not-intubate status. CPR was
performed in accordance with European Resuscitation
Council guidelines [1]. After the return of spontaneous
circulation (ROSC), the initial assessment of vital signs,
including 12-lead electrocardiogram and body tempera-
ture measurement, was performed. Then patients had
additional intravenous access placed and were cooled by
the rapid intravenous infusion of 4°C cold normal saline.
The recommended dose of coolant was 15 to 20 mL/kg.
During transport, patients were monitored as usual (con-
tinuous) electrocardiogram, heart rate, and peripheral
oxygen saturation). On arrival at the hospital, vital signs,
including body temperature, were reassessed. Afterwards,
in-hospital intensive care therapy, including TH, urgent
myocardial revascularization (if indicated), goal-directed
hemodynamic support, and control of blood glucose,
ventilation, and seizures as described by Sunde and col-
leagues [9], was performed in all ICUs.
Cold saline was stored in the refrigerator of every
ambulance and packed in bags of 250 or 500 mL. Body
temperature was measured tympanally. Every measure-
ment was repeated thrice and averaged for further ana-
lysis. During the transport, midazolam and fentanyl or
sufentanyl were used for sedation and analgesia, and
pipecuronium was administered for muscle paralysis.
When necessary, continual infusion of noradrenaline or
dopamine was used for circulatory support.
All treatment decisions and interventions in the field
were made by emergency physicians only.
The control group patients were resuscitated in the
1-year period before the study was initiated and were
selected consecutively from the health documentation of
both administrative regions. The same inclusion and
exclusion criteria as in the TH group patients were ret-
rospectively applied to minimize selection bias. The con-
trol group patients underwent a standard process of
CPR and pre-hospital and in-hospital care according to
the guidelines, including in-hospital therapeutic
hypothermia, but did not undergo any pre-hospital cool-
ing attempt [1].
All resuscitation details and characteristics of the pre-
hospital and in-hospital courses were recorded in
Utstein style [10]. Classification of the different types of
causes of cardiac arrest followed the European Resusci-
tation Council Guidelines for Resuscitation (2005) and
European Society of Cardiology guidelines [1,11,12]. The
definite identification of cardiac arrest was based on the
individual assessment of the medical history, prodromal
pre-arrest symptoms, pre-hospital clinical examination
(including 12-lead electrocardiogram), in-hospital course
of the disease, and the autopsy results, if indicated.
Outcome assessment
The primary endpoint was a decrease of tympanic tem-
perature (TT) from baseline to hospital admission.
Secondary endpoints were the possibility of achieving a
TT of not more than 34°C on hospital admission, the
pre-hospital (and early in-hospital, respectively) inci-
dence of the post-resuscitation adverse events, and the
presence of a favorable neurological outcome at hospital
discharge. Monitored adverse events of cooling were the
new onset of pulmonary edema during transport and
within 12 hours after admission, bradycardia, non-sus-
tained ventricular tachycardia/fibrillation, recurrence of
cardiac arrest and ongoing CPR at the hospital, and the
need of vasopressoric support for hypotension during
transport. The neurological outcome was assessed by
the cerebral performance category (CPC) scoring sys-
tem. Categories 1 and 2 were considered favorable [10].
Statistical analysis
Mean values ± standard deviation or percentages were
calculated for all variables. Differences between the
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significance was calculated by the Fisher exact test for
alternative variables. The statistical significance for con-
tinuous variables was determined by the Student t test.
To analyze the impact of transport duration on the
cooling efficacy, we divided the transport duration into
four quartiles. Independent predictors of the presence of
favorable neurological outcome at hospital discharge
were evaluated by multivariate logistic regression analy-
sis of a sample of all 80 patients from both groups
together. Data were analyzed with JMP 3.2 statistical
software (SAS Institute Inc., Cary, NC, USA). A P value
of less than 0.05 was considered statistically significant.
Results
Baseline characteristics and demographic data
A total of 41 patients underwent baseline assessment.
One of them died before any cooling attempt. Another
40 patients were cooled following the protocol (TH
group). The same number of patients was included in
the control group. Table 1 summarizes the baseline
demographic data, and Table 2 summarizes the charac-
teristics of cardiac arrest causes and the CPR process. In
the TH group, more patients received bystander CPR.
Cooling procedure
In the TH group, the administration of 12.6 ± 6.4 mL/
kg (1,032 ± 546 mL) of 4°C normal saline led to a TT
decrease of 1.4 ± 0.8°C (from 36.2 ± 1.5 to 34.7 ± 1.4°C;
P < 0.001) in 42.8 ± 19.6 minutes. The TT decrease fol-
lowing the administration of at least 12.6 mL/kg of
coolant was more intense than the decrease induced by
a lower dose (-1.8 ± 0.7 versus -1.1 ± 0.7; P = 0.008).
A TT of not more than 34°C was reached in 17.5% of
cooled patients, and a TT of not more than 35°C was
reached in 52.5% of cooled patients. The administered
volume of cold saline correlated linearly with a pre-hos-
pital decrease of TT in the TH group (r = -0.611, P <
0.001). The impact of pre-hospital transport time on the
decrease of TT achieved is shown in Figure 1. The most
effective cooling was associated with a transport time
of 38 to 60 minutes and with the administration of
17 mL/kg of cold saline.
There was no significant difference in time from col-
lapse to hospital arrival between the groups (TH group:
59.6 ± 29.5 minutes, control group: 61.6 ± 23.8 minutes;
P = 0.746). Underdosing of coolant was observed in 23
(57.5%) patients in the TH group. The most frequent
reported cause was a short pre-hospital transport time
(73.9%). In the two groups, we observed a comparable
incidence of post-resuscitation adverse events (Table 3).
In the TH group, a trend toward a lower need of cate-
cholamines during transport was detected (Table 3).
In-hospital therapy and neurological outcome
Patients in the two groups did not differ in the in-hospital
markers of the severity of post-cardiac arrest syndrome, in
the intensity of organ-supporting therapy, or in the
number of patients treated by in-hospital TH (Table 4).
The majority of patients in both groups underwent in-
hospital cooling (TH group: 85.0%, control group: 80.0%;
P = 0.556).
Table 1 Baseline demographic variables
TH group Control group P value
Number of patients 40 40
Age, years 61.4 ± 18.1 61.3 ± 17.3 0.975
Males 34 (85.0) 29 (72.5) 0.274
Body weight, kg 83.6 ± 17.0 81.3 ± 18.1 0.571
Arterial hypertension 24 (60.0) 23 (57.5) 0.820
Diabetes mellitus 13 (32.5) 10 (25.0) 0.459
Active smokers 15 (37.5) 14 (35.0) 1.000
Hyperlipoproteinemia 12 (30.0) 10 (25.0) 0.616
History of myocardial infarction 17 (42.5) 13 (32.5) 0.356
History of PCI or CABG or both 10 (25.0) 8 (20.0) 0.592
Congestive heart failure 10 (25.0) 12 (30.0) 0.616
Significant valvular disease 4 (10.0) 5 (12.5) 0.723
Peripheral vascular disease 5 (12.5) 7 (17.5) 0.754
Chronic renal failure 7 (17.5) 2 (5.0) 0.077
Chronic pulmonary disease 9 (22.5) 10 (25.0) 0.793
History of endocrinous disease 2 (5.0) 2 (5.0) 1.000
History of psychiatric disorder or alcoholism 8 (20.0) 8 (20.0) 0.692
Values other than ‘Number of patients’ and P values are expressed as mean ± standard deviation or as number (percentage). CABG, coronary artery bypass graft
surgery; PCI, percutaneous coronary intervention; TH, therapeutic mild hypothermia.
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d e n c eo faf a v o r a b l en e u r o l o g i c a lo u t c o m ea th o s p i t a l
discharge and to lower in-hospital mortality than in the
control group (Table 4). Providing of bystander CPR
w a sa s s o c i a t e dw i t hat r e n dt oi m p r o v e di n c i d e n c eo fa
favorable neurological outcome in the TH group
(bystander CPR: 53.8%, no bystander CPR: 28.6%; P =
0.125) but not in the control group (bystander CPR:
23.5%, no bystander CPR: 30.4%; P = 0.629).
The coupling of pre-hospital hypothermia with subse-
quent in-hospital cooling was associated with the higher
frequency of favourable neurological outcome at hospital
discharge than other treatment (in-hospital or pre-hos-
pital cooling only or no TH) (52.9% versus 23.9%; P =
0.008) throughout the whole sample of all 80 patients.
Multivariate analysis confirmed the predictive value of
the coupled approach for a favourable neurological out-
come at discharge (odds ratio [OR] 4.1, 95% confidence
interval [CI] 1.1 to 18.2; P = 0.046). The other signifi-
cant positive predictor was the presence of ventricular
fibrillation as the initial rhythm (OR 4.26, 95% CI 1.1 to
18; P = 0.039) and the negative predictor was time from
collapse to ROSC of more than 22 minutes (OR 0.21,
95% CI 0.05 to 0.71; P = 0.019). Other parameters such
as age, medical history of diabetes mellitus, cause of
OHCA, time from ROSC to hospital arrival, providing
of bystander CPR, recurrence of cardiac arrest, and the
need for use of catecholamines during transport did not
reach significant value.
Discussion
The main finding of our analysis is that pre-hospital
induction of TH by RIVA in successfully resuscitated
OHCA patients led to a significant TT decrease despite
relatively low doses of cold normal saline. The positive
impact of TH on the prognosis of OHCA survivors has
been shown by several studies [13-16]. In accordance
with the recommendation of initiating TH as soon as
possible, moving of the first cooling attempt to the pre-
hospital phase seems to be a step leading to very early
intervention. Evidence of further prognosis improvement
by pre-hospital cooling has not been shown yet. How-
ever, a battery of other arguments, particularly the
pathophysiological principle of cerebral ischemia-
reperfusion injury per se and the results of animal
experiments and of some clinical studies in humans,
favor this approach [17-21]. Recently, Castrén and col-
leagues [22] reported the results of the clinical study
PRINCE (Pre-Resuscitation Intra-Nasal Cooling
Effectiveness), which showed in the subgroup analysis
the improvement of prognosis of OHCA patients by
pre-hospital intranasal intra-arrest cooling.
Mostly, the studies analyzed the pre-hospital induction
of TH by the RIVA technique [2-5].
Virkkunen and colleagues [2] cooled 13 pre-hospital
cardiac arrest patients by the rapid administration of
30 mL/kg of ice-cold Ringer’s solution. The authors
achieved a pre-hospital decrease of esophageal tempera-
ture of 1.8°C [2]. In a later study, Kim and colleagues
Table 2 Cardiac arrest causes, initial rhythm, and cardiopulmonary resuscitation variables
TH group Control group P value
Causes of cardiac arrest
STEMI 12 (30.0) 13 (32.5) 0.809
NSTEMI/unstable angina 8 (20.0) 3 (7.5) 0.104
Complication of congestive heart failure 8 (20.0) 9 (22.5) 0.785
Pulmonary embolism 2 (5.0) 3 (7.5) 0.644
Metabolic 2 (5.0) 4 (10.0) 0.396
Secondary hypoxic 5 (12.5) 6 (15.0) 0.745
Unknown 3 (7.5) 2 (5.0) 0.644
Initial rhythm
Ventricular fibrillation 21 (52.5) 18 (45.0) 0.655
Asystole 15 (37.5) 14 (35.0) 1.000
Pulseless electrical activity 4 (10.0) 8 (20.0) 0.348
CPR variables
Time from collapse to any resuscitation attempt, minutes 4.0 ± 3.0 4.5 ± 3.4 0.454
Time from collapse to ROSC, minutes 26.8 ± 16.9 25.4 ± 13.9 0.695
Any bystander CPR attempt 26 (65.0) 17 (42.5) 0.043
Cumulative defibrillation energy in ventricular fibrillation patients, J 877 ± 763 1,097 ± 1,099 0.468
Cumulative epinephrine dose, mg 4.7 ± 4.5 4.5 ± 3.6 0.892
Device-based heart massage 5 (12.5) 4 (10.0) 0.723
Values other than P values are expressed as number (percentage) or as mean ± standard deviation. CPR, cardiopulmonary resuscitation; NSTEMI, non-ST-segment
elevation myocardial infarction; ROSC, return of spontaneous circulation; STEMI, ST-segment elevation myocardial infarction; TH, therapeutic mild hypothermia.
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care with or without intravenous cooling pre-hospitally
(500 to 2,000 mL of 4°C normal saline). In the
hypothermia group, 87% of patients were cooled, and
they achieved a clinically relevant pre-hospital decrease
of esophageal temperature when compared with
the control group (1.24 ± 1.09°C versus 0.10 ± 0.94°C;
P < 0.001). Pre-hospital cooling was safe and was asso-
ciated with a trend toward improved survival of patients
who received cooled ventricular fibrillation prior to hos-
pital arrival [3]. Recently, Kämäräinen and colleagues [4]
randomly assigned 37 patients to pre-hospital cooling or
standard care. The administration of 27 mL/kg of cold
normal saline to 19 patients led to a decrease in
Figure 1 The impact of transport duration on the cooling rate and on the decrease of tympanic temperature (TT) during transport.
*P for dose of cold saline; **P for pre-hospital TT decrease.
Table 3 The pre-hospital incidence of post-resuscitation adverse events
TH group, number
(percentage)
Control group, number
(percentage)
P
value
Bradycardia 1 (2.5) 1 (2.5) 1.000
Non-sustained ventricular fibrillation/tachycardia 2 (5.0) 1 (2.5) 0.541
Recurrence of cardiac arrest 4 (10.0) 5 (12.5) 0.723
Requirement of vasopressors during transport 14 (35.0) 21 (52.5) 0.115
New pulmonary edema during transport and in 12 hours after
admission
0 (0) 1 (2.5) 0.314
Ongoing CPR at hospital arrival 3 (7.5) 5 (12.5) 0.456
CPR, cardiopulmonary resuscitation; TH, therapeutic mild hypothermia.
Škulec et al. Critical Care 2010, 14:R231
http://ccforum.com/content/14/6/R231
Page 5 of 8nasopharyngeal temperature of 1.5 ± 0.8°C, whereas 18
patients in the control group did not exhibit any tem-
perature change (0.1 ± 0.6°C; P < 0.001). A high propor-
tion of patients with a favorable neurological outcome
at discharge was observed (42% versus 44%; P >0 . 0 5 )
[4]. Finally, Hammer and colleagues [5] reported the
results of a French study. From a total of 99 patients, 22
were cooled by RIVA prior to hospital arrival and
9 (41%) of them reached a body temperature of less
than 35°C. The remaining 77 patients underwent a stan-
dard treatment and 14 (18%) of them experienced a
temperature drop to less than 35°C [5]. The studies,
though not designed primarily for analysis of neurologi-
cal outcome, clearly demonstrated that pre-hospital
applying of large amount of cold crystalloids is a safe
and effective procedure and that without an active cool-
ing approach, no significant spontaneous cooling occurs.
In our study, although the dose of coolant was consid-
erably smaller than those in the studies by Kämäräinen
and colleagues and Virkkunen and colleagues, we
observed a significant and clinically relevant pre-hospital
decrease of TT. This decrease was similar to the one
reported by Kim and colleagues, who observed a signifi-
cant decrease of esophageal temperature in those patients
who were administered both a full dose of 2,000 mL of
normal saline and a dose of between 500 and 2,000 mL.
However, even the correlation of the administered cool-
ant dose and reached TT decrease was linear in our
study, we want to stress that cooling effectiveness
depends not only on the dose of coolant but also on
other variables: First, cooling effectiveness depends on
the air temperature inside the ambulance and the infu-
sion bags’ temperature stability, which is defined particu-
larly by the initial infusion temperature, the type of
infusion package, the initial volume of the infusion bag,
and the infusion rate. Second, a period from the
completion of cooling until hospital arrival determines a
time period for potential unintentional rewarming of the
patient. Third, the patient’s cooling responsiveness,
which is related mainly to the suppression of shivering,
can influence cooling effectivity. Finally, the method of
measuring body temperature may be important. In our
study, infusion bags of no larger than 250 or 500 mL
were used. We can speculate that rapid and repeated
application of small-volume bags may reduce a sponta-
neous infusion rewarming during its administration and
may enhance the cooling potency. We consider that this
calls for further studies to optimize the pre-hospital
RIVA cooling procedure.
Moreover, our analysis showed that the decrease of
TT during pre-hospital transport followed the J curve.
The most intense TT decrease was associated with a
t r a n s p o r tt i m eo f3 8t o6 0m i n u t e s .L o n g e rt r a n s p o r t
time was not associated with the enhancement of cool-
ing efficacy, and a trend to rewarming was found. Pre-
viously, Kliegel and colleagues [23] demonstrated that
cold infusion alone fails to keep patients cool. Thus, we
propose that in the case of a transport time of more
than 45 minutes, the second reduced bolus of cold infu-
sion be considered.
An important issue is procedural safety. Neither in pre-
vious studies nor in our study was a higher incidence of
early post-resuscitation adverse events observed in the
cooling group. It is noteworthy that a trend toward a
lower frequency of the need for vasopressoric support
was recognized in the TH group. Kim and colleagues [3]
described a similar effect, and Kämäräinen and colleagues
[4] described the opposite. We can speculate that volume
expansion with normal saline can contribute to hemody-
namic stabilization in some patients. Previously, we
showed that fluid responsiveness of cardiac arrest survi-
vors with a low cardiac output is high in general [24].
Table 4 In-hospital course of the post-resuscitation disease and neurological outcome
TH group Control group P value
Number of days on mechanical ventilation 11.4 ± 16.4 14.3 ± 23.4 0.531
Number of days of ICU stay 16.0 ± 17.9 18.7 ± 27.1 0.596
Number of post-resuscitation organ dysfunctions 1.4 ± 1.4 1.3 ± 1.3 0.633
Major bleeding 3 (7.5) 6 (15.0) 0.288
Infection 19 (47.5) 17 (42.5) 0.653
Urgent coronary angiography 25 (62.5) 17 (42.5) 0.073
Direct PCI/CABG 14 (35.0) 14 (35.0) 0.813
Systemic thrombolysis 0 (0) 3 (7.5) 0.488
Intra-aortic balloon pump 4 (10.0) 4 (10.0) 1.000
Continual renal replacement method 2 (5.0) 3 (7.5) 0.644
CPC 1 or 2 at discharge 18 (45.0) 11 (27.5) 0.103
In-hospital mortality 15 (37.5) 22 (55.0) 0.116
Values other than P values are expressed as mean ± standard deviation or as number (percentage). CPC, cerebral performance category; ICU, intensive care unit;
PCI/CABG, percutaneous coronary intervention/coronary artery bypass graft; TH, therapeutic mild hypothermia.
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dynamic effect of the coolant is probably related to the
dose and infusion rate. Thus, it is possible that a dose of
10 to 20 mL/kg is more hemodynamically suitable than
30 mL/kg.
The impact of the procedure on the clinical outcome
was also analyzed. The neurological outcome at hospital
discharge in the TH group reflects the results of the
trials analyzing in-hospital and pre-hospital hypothermia
[4,9,25]. Bystander CPR was provided more frequently
in the TH group. Perhaps surprisingly, bystander CPR
was not associated with a clear improvement of the neu-
rological prognosis. A similar observation was reported
by Kämäräinen and colleagues [4]. The main reason for
this observation, in our view, is that providing bystander
CPR is the primary factor that determines whether
ROSC is achieved. In our study, we included only suc-
cessfully resuscitated OHCA patients. In this selected
group, the subsequent impact of bystander CPR on the
neurological outcome may be less intense, probably
demonstrable only by larger sample size.
Because not all patients in the two groups were trea-
ted by in-hospital hypothermia, the whole sample of 80
patients can be distributed into four subgroups accord-
ing to the performed cooling schedule: pre-hospital
cooling followed by in-hospital TH, in-hospital cooling
only, pre-hospital cooling only, and no administration of
TH. We believe that this distribution reflects real-life
practice and that is why we calculated the odds for the
first-mentioned approach. Despite the study limitations
(described below), the close coupling of pre-hospital TH
induction with its in-hospital continuation predicted a
favorable neurological outcome. We stress that this
coupling is not definite evidence of a benefit from
pre-hospital cooling. However, it suggests that early pre-
hospital TH induction closely followed by the sophisti-
cated in-hospital intensive care, including TH, can help
improve further prognosis. In any case, more studies are
required. In the future, a comparison of the RIVA
method with other pre-hospital cooling techniques like
surface cooling (as demonstrated by Uray and colleagues
[26]) or even an investigation of a combinatory pre-hos-
pital cooling approach would be beneficial.
There are some limitations to our study. First, the study
was not randomized. Second, body core temperature was
measured by one method (measurement was semi-continual
and tympanal). Third, in-hospital intensive care was
not controlled by the study protocol. Fourth, some out-
comes of the study are influenced by longer pre-hospital
times, reflecting local protocols and the availability of hospi-
tals with a catheterization laboratory. Fifth, experiences from
the physician-staffed EMS may not be completely applicable
by the other types of EMS.
Conclusions
Pre-hospital induction of TH by the RIVA method has
been shown to be efficient, even with the lower dose of
coolant as was investigated in previous studies. This
dose can be associated with the favorable impact on the
circulatory stability early after the ROSC and, when fol-
lowed by in-hospital TH, can potentially improve the
prognosis of the patients. We call for further studies to
optimize pre-hospital cooling by cold crystalloids for the
optimal cooling efficacy along with the beneficial effect
on hemodynamics.
Key messages
￿ Pre-hospital induction of therapeutic hypothermia
by a rapid intravenous administration of 4°C cold
normal saline can be effective, even with a dose of
about 15 mL/kg.
￿ Volume expansion associated with intravenous
cooling can contribute to hemodynamic stabilization.
￿ The close coupling of pre-hospital induction of
therapeutic hypothermia with its in-hospital con-
tinuation can help to improve the prognosis of
patients.
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